Looking to publish in Translational Neurodegeneration? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginTranslational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. It creates an interface between basic, translational, and clinical research and is affiliated with Ruijin Hospital.
Looking to publish in Translational Neurodegeneration? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Translational Neurodegeneration is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:
Research
Review
Correspondence
Research Highlight
Recent Publications
Levetiracetam restores GABAergic function and network homeostasis following Vps35 deficiency in excitatory neurons
Zhi-Peng Liu, Daehoon Lee, Zhibing Tan, Anika Wu, Lin Mei, Wen-Cheng Xiong
The glymphatic–lymphatic axis: known pathways, open questions, and emerging roles in neurodegeneration
Yumeng La, Jin Yuan, Jun Chen, Kejia Lv, Xiaoxi Wang, Qiqi Gao, Yujue Wang, Chen Wang, Bin Xu, Ying Yang, Jing Zhang
Fyn kinase: a key mechanistic regulator and therapeutic target in tauopathy and neurodegenerative diseases
Haiwen Wang, Xing Fan, Jianchao Ping, Qian Shao, Cai Wang, Hao Wang, Qiuhong Ji, Min Su, Wei Qian
Microglia-derived extracellular vesicle content as a biomarker for early detection of Alzheimer’s disease
Amber L. Woudstra, Linda Holtman, Erwin A. van Vliet
Large-scale genetic profiling of hereditary ataxias in China: implications for a stepwise molecular diagnostic strategy
Jin-Yang Yu, Yi-Min Sun, Yi Dong, Jian-Jun Wu, Chen-Hao Zhu, Yi-Chu Du, Yi-Xin Zhang, Yue Zhang, Sheng-Mei Zou, Yin Ma, Hai-Lin Dong, Zhi-Ying Wu
Frequently asked questions
How long does it take to publish?
Submission to first decision (median): 11 days.
Reformat to Translational Neurodegeneration using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should explain why the manuscript should be published in Translational Neurodegeneration, address any issues relating to journal policies, declare any potential competing interests, confirm that all authors approved the submission, confirm that the manuscript has not been published or submitted elsewhere, and name the special issue if applicable. Authors may also suggest preferred and non-preferred peer reviewers in the cover letter.
Reformat to Translational Neurodegeneration using Livewrite PremiumWhat are the publication costs?
An article processing charge applies for each accepted article. The current APC is £2290.00 GBP / $3090.00 USD / €2690.00 EUR. The APC for a Research Highlight or Correspondence is £1590.00 GBP / $2180.00 USD / €1890.00 EUR.
Reformat to Translational Neurodegeneration using Livewrite Premium